Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.


Search All Patents:



  This Patent May Be For Sale or Lease. Contact Us

  Is This Your Patent? Claim This Patent Now.



Register or Login To Download This Patent As A PDF




United States Patent Application 20180110639
Kind Code A1
Alverdy; John C. April 26, 2018

BALLOON SYSTEM AND METHODS FOR TREATING OBESITY

Abstract

A medical system for the treatment of morbid obesity comprising an inflatable balloon implanted in a gastric cavity, a percutaneous fillant delivery tube and a control module connected to the tube for regulating the inflation and deflation of the balloon. The balloon may be individually contoured and inflated to occupy a large volume of the gastric cavity to provide a feeling of satiety. The balloon may also be deflated to give the gastric cavity lining a rest during less critical time.


Inventors: Alverdy; John C.; (Glenview, IL)
Applicant:
Name City State Country Type

ReShape Medical, Inc.

San Clemente

CA

US
Family ID: 1000003083035
Appl. No.: 15/614264
Filed: June 5, 2017


Related U.S. Patent Documents

Application NumberFiling DatePatent Number
14286847May 23, 20149668900
15614264
12625473Nov 24, 20098845672
14286847
12257724Oct 24, 2008
12625473
10513583Nov 2, 2004
PCT/US03/12782Apr 25, 2003
12257724
60379540May 9, 2002

Current U.S. Class: 1/1
Current CPC Class: A61F 5/004 20130101; A61F 5/003 20130101
International Class: A61F 5/00 20060101 A61F005/00

Claims



1-7. (canceled)

8. A method to treat obesity, said method comprising: connecting a distal end of a fillant delivery tube to a balloon, said fillant tube comprising a separate component with said distal end and proximal end; connecting said proximal end of said fillant delivery tube to a control module, said control module including a pump for introducing a fillant to said balloon; implanting said balloon in the patient's stomach; using said control module and pump to automatically and fully inflate said balloon with said fillant, said fully inflated balloon providing ac contour occupying the majority of the volume of the stomach; and said fully inflated balloon providing a balloon surface contacting a major portion of said stomach wall, wherein the inflated balloon is configured to elicit a signal to cause a feeling of satiety.

9. A method of claim 8 wherein the balloon is made from a surgical grade material.

10. The method of claim 8 wherein the balloon i made from rubber which expands upon introduction of said fillant.

11. The method of claim 8 wherein the tube is made from a surgical grade material.

12. The method of claim 8 wherein the tube is constructed of a metal or plastic material.

13. The method of claim 8 wherein said feeling of satiety is from the stomach itself.

14. The method of claim 8 wherein said feeling of satiety is created by balancing physiological, neurohormonal and chemical factors of said patient.

15. A system for treating obesity comprising: a. an inflatable elastomeric balloon having distal and proximal regions and adapted for implantation in a gastric space; a fillant delivery tube extending through the balloon and affixed to the distal and proximal regions of the balloon, the tube terminating at the distal region of the balloon; a control module connected to a proximal end of the tube and configured to cyclically inflate and deflate the balloon across a plurality of cycles throughout a predetermined period of time according to a program; wherein the tube imparts a reference shape to the deflated balloon; and wherein the balloon is configured to expand to a shape that is axially constrained by the fillant delivery tube; wherein the balloon is individually designed to meet specific morphologic features of a patient's stomach such that it is contoured to occupy the vast majority of a volume of the stomach in an inflated state.

16. The system of claim 15, wherein balloon is filled with at least one gas, liquid, or gel.

17. The system of claim 15, wherein the uninflated balloon is a first size and configured to inflate with at least one gas, liquid and gel to a size at least three times the size of the uninflated balloon size.
Description



RELATED APPLICATION

[0001] This application is a continuation-in-part application of and claims the benefit and priority of U.S. patent application Ser. No. 10/513,583, filed Nov. 2, 2004, and a continuation-in-part application of and claims the benefit and priority of U.S. patent application Ser. No. 12/257,724, filed Oct. 24, 2008, the contents of which are incorporated by reference herein in its entirety.

BACKGROUND

Field

[0002] This invention generally relates to the treatment of morbid obesity and, more specifically, to a system and method for treating morbid obesity using a variably cycled percutaneous balloon implanted in the gastric cavity.

General Background

[0003] Morbid obesity is a major health problem confronting the general public and health care industry today. It is estimated that approximately 50% of the U.S. population is overweight and over ten million Americans are more than 100 pounds over their ideal weight. Generally, a person is considered morbidly (or seriously) obese if they are 100 pounds or more over their ideal weight. The morbidly obese group faces increased health risks including a higher likelihood of heart disease, hypertension, diabetes and certain cancers. Over 300,000 Americans die of obesity related illnesses each year. In addition, the morbidly obese generally have lower self-esteem and are more likely to suffer from depression than the general public.

[0004] Most obese individuals have struggled unsuccessfully with their weight for a lifetime. The numerous diets, behavioral therapy and treatments such as hypnosis, pituitary hormones and appetite suppressant drugs attest to the great difficulty many overweight people have in losing weight and keeping it off. Some of these weight loss strategies can be successful in the mildly obese people, but nearly all fail in individuals considered morbidly obese. These disappointing results have led many patients and their doctors to consider surgery as an option for weight loss.

[0005] Surgical techniques bring about weight loss primarily by limiting how much the stomach can hold. Today's most common surgical procedures to promote weight loss focus on decreasing food intake by restriction. Gastric banding, gastric bypass and vertical-banded gastroplasty are surgeries that limit the amount of food the stomach can hold by closing off or removing parts of the stomach. Other surgeries attempt to permanently fill the stomach with an inflated balloon. These treatments are invasive, require major surgery with hospitalization and are associated with complications.

[0006] The success rates of current treatments and procedures have been poor. With the restrictive procedure, the patient is usually limited to eating very small amounts of food at a time. For many people, this can create a "satisfied" feeling, but they often do not feel "full". The ability to eat a large amount of food at one time is lost; consequently, many patients return to eating excessive amounts of high calorie or high sugar liquid foods. Essentially, their diet includes milk shakes and ice cream.

[0007] As to the balloon procedure of the past, very limited positive results were achieved. The balloon was relatively small when compared to the overall volume of the morbidly obese stomach. This is due to physiological limitation on the balloon volume. That is, complications of the device precluded enlarging it to a volume that would occupy more of the stomach. Yet, in order for the balloon to achieve a patient's feeling of fullness and satiation, the balloon would need to occupy a large portion (volume) of the patient's stomach. A balloon occupying this much volume without fixation or an inflation/deflation cycling has the potential of blocking food flow and causing necrosis of the stomach wall, ulcers and/or bleeding.

[0008] Moreover, success depends on the ability of a treatment to "normalize" not only the mechanical and neurohormonal sensation of feeling full and satiated, but also involves psychological factors. Both the mechanical and neurohormonal factors relate to one's need to feel "full" and "satiated". Chemicals released by the stomach during the digestive process largely drive these factors. In other words, filling the stomach or limiting its pouch size controls these chemicals. Current surgical approaches, however, fail to achieve this global feeling of "satiety" response as they restrict food entry only into the small proximal stomach pouch and bypass the distal stomach where most of the neurohormonal chemical are normally released. Medical therapy is focused almost exclusively at the brain level and is likely to continue to fail as patients experience mood disorders and complications from medications. Accordingly, there is a need for a system and method for treating morbid obesity by restoring or normalizing the appropriate "fullness signals" from the stomach itself as this is the organ that regulates fullness. In particular, the system and method of the invention should cause a feeling of satiety from the stomach itself with less consumption of food by a morbidly obese patient.

SUMMARY

[0009] A system and method for treating morbid obesity using a variably cycled percutaneous balloon implanted in the gastric cavity to elicit signals directly from the entire stomach in order to cause a feeling of satiety with less food. This novel approach has the potential to offer a less invasive, more complete elicitation of the feeling of fullness in patients who chronically, and perhaps genetically overeat. The system of the invention includes a balloon device that is contoured to occupy the vast majority of the volume of the stomach. The system also has the capacity to automatically inflate and deflate the balloon, thereby avoiding the problem of pressure induced injury. With the advent of CT scanning and 3-dimensional imaging, patients may have balloons individually designed to meet the specific morphologic features of their stomachs. By fixation of the balloon device, the problems of migration and obstruction are avoided. Furthermore, the system and process of the invention apply appropriate inflation/deflation cycling with a computerized device so as to avoid complications of past devices.

[0010] These and other features and advantages of the invention will become more apparent with a discussion of preferred embodiments in reference to the associated drawings.

DRAWINGS

[0011] FIG. 1 illustrates a schematic view of a variably cycled percutaneous balloon placed within the gastric cavity of an individual in accordance with an embodiment of the invention; and

[0012] FIG. 2 illustrates a cross-sectional view of an inflatable balloon and a fillant delivery tube according to the present invention.

DETAILED DESCRIPTION

[0013] With reference to FIGS. 1 and 2, a variably cycled percutaneous balloon system 100 for treating morbid obesity is illustrated and comprises an inflatable balloon no individually contoured to each patient's stomach, a percutaneous inflation or fillant delivery tube 120 having a proximal end and a distal end connected to the balloon no, and a control module 130 connected to the proximal end of the tube 120. The tube 120 includes at least one opening 115 for filling the balloon 110 with a biocompatible fillant. The control module 130 variably controls the inflation and deflation of the balloon no with the biocompatible fillant such as a liquid, gas, gel or a mixture thereof. In accordance with the teachings of the present invention, the tube 120 is passed through and affixed to abdominal wall 160 and stomach wall 150. The balloon no is then positioned into the stomach or gastric cavity 140. The positioning of the balloon 110 may be done, e.g., by the percutaneous endoscopic gastrostomy (PEG) technique, which is known in the art. The balloon no and tube 120 may be separate or integral components that are constructed from any surgical grade material. For example, the balloon no may be made from latex rubber which expands upon introduction of a fillant, and the tube 120 may be constructed of a metal or plastic material. The tube 120 is connected to the control module 130, which may be a fixed unit or a portable unit mounted to the patient's side. The control module 130 may be a personal computer such as a desktop computer, a laptop computer or a handheld computer. The control module 130 further includes a device such as a pump for introducing and removing a fillant to and from the balloon no.

[0014] A novel feature of the system 100 is it variably controls the inflation and deflation of the balloon no. For example, the system 100 may inflate and deflate the balloon no throughout a predetermined period of time such as a 24-hour period. The balloon no would occupy a large volume of the stomach 140 (as shown by reference number 110(a)) when it would be most beneficial for weight loss, and deflate to give the stomach lining a rest (as shown by reference number 110(b)) during less critical time, e.g., during sleeping time. Furthermore, an algorithm tailored to each patient's needs and programmed into the control module 130 is used to control the balloon size to minimize the desire to eat and to prevent blockage or stomach lining necrosis. Unlike the restrictive procedures of the prior art, the variable inflated balloon no would not limit nutrient absorption and not lead to altered food choices. This is achieved as the balloon no contacts a major portion of the stomach wall 150 when the balloon no is fully inflated. Thus, the system 100 of the invention creates a feeling of fullness and satiation by balancing the physiological, neurohormonal and chemical factors.

[0015] It will be understood that many modifications can be made to the disclosed embodiments without departing from the spirit and scope of the invention. As such, the above description should not be construed as limiting the invention, but should be interpreted as merely exemplary of preferred embodiments.

* * * * *

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.